Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 16 Mar 2022 for Alzamend Neuro, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Jeffrey Oram: trading record in brief
This profile gathers the share dealings of Jeffrey Oram in Alzamend Neuro, Inc., where the filings describe the role as board member. We count 3 filings; the first trade dates from 13 September 2021 and the latest from 15 March 2022.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 16 March 2022, the filings show an option exercise in Alzamend Neuro, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jeffrey Oram
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
50,000 shares0Common StockSEC:0001214659-22-004010:0
47,222 shares0Common StockSEC:0001214659-21-010560:0
2,778 shares0Common StockSEC:0001214659-21-009542:0
3 of 3 declarations
